Aidoc Raises $150 Million in Series E Funding Led by Growth Equity at Goldman Sachs Alternatives

Aidoc secures $150 million in Series E funding led by Growth Equity at Goldman Sachs Alternatives to expand its clinical foundation model and enterprise AI platform, aiming to combat diagnostic harm and improve efficiency across health systems.